Half-year report · HY
8095.TEDINET S100YQAP
Period2025-12-01 → 2026-05-31
Filed2026-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥62.7bn | 2024-12-01 → 2025-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2025-12-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2025-12-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2025-12-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2025-12-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2025-12-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥74.9bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥75.9bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥65.5bn | at 2025-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.1bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥48.5bn | at 2025-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥28.8bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.4bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥26.0bn | at 2025-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.2bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.2bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.6bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.2bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥775m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.1 | 2025-12-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.36 | 2024-12-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.97 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 38.0% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-12-01 → 2026-05-31 | ¥38m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-12-01 → 2026-05-31 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-12-01 → 2026-05-31 | −¥128m |
| Reconciling Itemsreconciling | revenue | 2025-12-01 → 2026-05-31 | −¥648m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-12-01 → 2026-05-31 | −¥648m |
| Reconciling Itemsreconciling | segment profit | 2025-12-01 → 2026-05-31 | ¥68m |
| Fine Chemicalsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Fine Chemicalsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥10.9bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥434m |
| Fine Chemicalsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥729m |
| Health And Beauty Care Foodreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥37m |
| Health And Beauty Care Foodreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥360m |
| Industrial Chemicalsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥6.0bn |
| Industrial Chemicalsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥6.0bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥1m |
| Industrial Chemicalsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥606m |
| Medicalreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥6.4bn |
| Medicalreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥6.3bn |
| Medicalreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥172m |
| Medicalreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥658m |
| —segment total | revenue | 2025-12-01 → 2026-05-31 | ¥35.2bn |
| —segment total | revenue external | 2025-12-01 → 2026-05-31 | ¥34.5bn |
| —segment total | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥645m |
| —segment total | segment profit | 2025-12-01 → 2026-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-12-01 → 2026-05-31 | ¥35.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-12-01 → 2026-05-31 | ¥34.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥648m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-12-01 → 2026-05-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-05-31 | ¥25m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-05-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-05-31 | −¥202m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-05-31 | ¥139m |
| Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥11.9bn |
| Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥11.6bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥319m |
| Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥871m |
| Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥8.1bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥8.0bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥48m |
| Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥544m |
| Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥1m |
| Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥190m |
| Medicalreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥6.2bn |
| Medicalreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥6.0bn |
| Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥152m |
| Medicalreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥679m |
| —segment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| —segment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥521m |
| —segment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥529m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 597
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋本町４－８－２ | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社(役員報酬ＢＩＰ信託口)(注)１ | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１－８－１赤坂インターシティＡＩＲ | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)岩城 慶太郎 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)石川県珠洲市 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)中央化学産業株式会社 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都目黒区中町２-５-２ | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)アステナホールディングス株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都中央区日本橋本町４－８－２ | |
| Name of shareholder treasury shares etc | InterimInstant_Row2Member | Original text (Japanese)ボーエン化成株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row2Member | Original text (Japanese)埼玉県和光市新倉７－９－32 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes additional information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | InterimInstant | Text · Plus | |
| Money consumption loan agreement by syndication method (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Notes regarding impairment loss (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes business combinations semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |